Duquesne Family Office’s 13F portfolio value rose to ~$4.49B in Q4 2025, with 35 significant positions led by Natera, Insmed, Amazon.com, Teva Pharma, and Woodward. Major new stakes include Alcoa, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results